SSN on Facebook SSN on Twitter SSN on YouTube RSS Feed


Francis Rooney Wants More Transparency When Drug Companies Raise Prices

May 25, 2019 - 7:15am
Francis Rooney
Francis Rooney

A Southwest Florida Republican congressman is backing a proposal to have pharmaceutical companies have more transparency when they want to raise drug prices. 

This week, U.S. Rep. Francis Rooney, R-Fla., joined U.S. Sens. Tammy Baldwin, D-Wisc., and Mike Braun, R-Ind., and U.S. Rep. Jan Schakowsky, D-Ill., in bringing out the “FAIR Drug Pricing Act” which, they insist, will be “the first step in addressing skyrocketing prescription drug prices by requiring transparency for pharmaceutical corporations that plan to increase drug prices.”

The bill would make drug companies reveal more information on their cost increases, including research and development expenses. 

“Specifically, the FAIR Drug Pricing Act would require drug manufacturers to notify the U.S. Department of Health and Human Services (HHS) and submit a transparency and justification report 30 days before they increase the price of certain drugs that cost at least $100 by more than 10 percent in one year or 25 percent over three years. The report will require manufacturers to provide a justification for each price increase, manufacturing, research and development costs for the qualifying drug, net profits attributable to the qualifying drug, marketing and advertising spending on the qualifying drug, and other information as deemed appropriate. The bill will not prohibit manufacturers from increasing prices, but it will, for the first time, give taxpayers notice of price increases and bring basic transparency to the market for prescription drugs,” Rooney’s office noted. 

Rooney weighed in on why he was backing the proposal on Thursday.  

“The rising cost of prescription drugs is spiraling out of control,” Rooney said. “Millions of Americans cannot afford their medication, putting their lives and health at risk, and costing taxpayers billions in Medicare costs. Prices must be lowered, and access to vital drugs must increase for American consumers. My goal is to lower prescription drug prices by increasing transparency, and that is why I am introducing the FAIR Drug Pricing Act- to make big pharmaceutical companies justify the price hikes on the medicines that Americans need.”

“For too long, I’ve heard story after story from Wisconsinites who are struggling to afford the life-saving medications they need,” said Baldwin. “Drug corporations are making prescription drugs more and more expensive with no systematic transparency to taxpayers. My bipartisan reform will change that and demand answers from drug companies who are jacking up the prices on the medications that Americans need. It is time for Congress to take action and take on the rising costs of medicine people depend on.”

“It’s time for pharmaceutical companies to clean up their act, otherwise they will be stuck with one customer: the federal government,” said Braun. “This legislation will help push them into the right direction by requiring transparency and justification before drug companies can increase the cost of certain drugs by more than 10 percent over one year or 25 percent over three years.”

“Drug pricing reform is a bipartisan priority that we must address now,” said Schakowsky. “The American people are demanding to know why life-saving prescription drugs that are developed with their taxpayer dollars cost them so much. I am proud that Senators Tammy Baldwin and Mike Braun have now joined me and Representative Rooney in introducing this long overdue legislation to expose the profiteering of drug corporations. The bill will for the first time give taxpayers notice of price increases and bring basic transparency to the market for prescription drugs. There are no loopholes or carveouts in this bill, and I hope that my colleagues will join me in fighting for the passage of this bill so that Big Pharma will finally have to answer to answer to the American people.”

The bill has reeled in the support of a number of groups including the AARP, the Campaign for Sustainable Rx Pricing, the National Multiple Sclerosis Society, Patients For Affordable Drugs, American College of Physicians (ACP), the American Academy of Neurology, the Blue Cross Blue Shield Association, the Medicare Rights Center, Families USA and several others. 


was at court june 3 , 915 am ford motor creidit company LLC sueing me moody,jones &ingino ,PA attorney for plaintiff 1333 drive ,suite 201 plantation florida 33324-4001 telephone 954-473-6605 michaelj.ingino michaelj.ingino,esquire yes he is lawer handing sue gave paper forida ruaral legal service,s inc yes told because have anything give them judge gave me person number give legal service hope office read my message

Where have you been for the last 40 years there Francis. Seems you clowns have been on the take for that long, but now you want to look like you are doing something since you have been called out on Nat'l TV... You can't make this stuff up...

The House and Senate ... or Dumpty Trumpty by executive order ... should simply put a price freeze on all existing drugs and/or medications. There are no worse predators in the current economic arena than the so-called "drug companies". Time to develop import agreements with the countries that have the lowest drug prices. Personally, I've heard of an HIV-maintenance drug that costs $2.000 per month in the U.S. ... and $8 per month in Austrailia!

Let's hope that this happens. For too long and many people have been aware, take a look at Dr. Marcia Angell and her book- do ordinary thieves disguise them selves in nice business suits and get away with such thievery? Ask the next politician who seeks your vote.

Comments are now closed.

Live streaming of WBOB Talk Radio, a Sunshine State News Radio Partner.